Technology | November 12, 2008

Medtronic Launches Endeavor Sprint DES on Rapid Exchange System

November 13, 2008 - Medtronic Inc. today started its U.S. market launch of the Endeavor Sprint drug-eluting stent (DES) on a rapid exchange (RX) delivery system.

Using the Sprinter balloon catheter technology, the Endeavor Sprint system puts the Endeavor DES on an enhanced delivery platform, making Medtronic’s flagship DES easier for physicians to deliver to the site of coronary blockages. The Endeavor Sprint system incorporates a new tip design for a low profile, a new balloon material and an enhanced shaft design which together greatly improve the device’s deliverability.

“The Endeavor Sprint system takes deliverability to a new level,” said Professor Ian Meredith of Monash Medical Centre in Australia. “It features a balloon catheter designed specifically for the stent it delivers. Combining it with RX, the Endeavor Sprint system further enhances the deliverability of the Endeavor DES, which already had high marks on this aspect of procedural success - even in challenging lesions.”

“Deliverability is important,” said Jeffrey Popma, M.D., of Caritas Christi Health Care System in Boston, “But the Endeavor stent also offers the assurance of long-term safety and durable efficacy. It’s the combination of all three attributes that will make the Endeavor Sprint DES system such a welcome addition for physicians to use in treating patients with coronary artery disease.”

The ENDEAVOR clinical program has demonstrated the Endeavor stent is associated with low rates of stent thrombosis, myocardial infarction and cardiac death, as well as low and comparable rates of clinically-driven target lesion revascularization, out to as long as five years of patient follow-up. Representing various world geographies and patient subsets, the program has enrolled more than 10,000 subjects to date and will ultimately enroll more than 20,000 subjects in a combination of randomized controlled and single-arm clinical trials.

For more information: www.medtronic.com


Additional Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
Subscribe Now